Joint Formulary & PAD

Nimodipine - Subarachnoid haemorrhage

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
  • Tablets
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Nimodipine
Indication :
Subarachnoid haemorrhage
Group Name :
Keywords :
ischaemic neurological defects, aneurysmal subarachnoid haemorrhage
Brand Names Include :
Nimotop
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Nimodipine is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Subarachnoid haemorrhage.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.